rs3735935
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000503.6(EYA1):c.1476-21G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.323 in 1,610,736 control chromosomes in the GnomAD database, including 91,815 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.32 ( 8629 hom., cov: 33)
Exomes 𝑓: 0.32 ( 83186 hom. )
Consequence
EYA1
NM_000503.6 intron
NM_000503.6 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.593
Publications
11 publications found
Genes affected
EYA1 (HGNC:3519): (EYA transcriptional coactivator and phosphatase 1) This gene encodes a member of the eyes absent (EYA) family of proteins. The encoded protein may play a role in the developing kidney, branchial arches, eye, and ear. Mutations of this gene have been associated with branchiootorenal dysplasia syndrome, branchiootic syndrome, and sporadic cases of congenital cataracts and ocular anterior segment anomalies. A similar protein in mice can act as a transcriptional activator. Alternatively spliced transcript variants have been identified for this gene. [provided by RefSeq, Dec 2013]
EYA1 Gene-Disease associations (from GenCC):
- branchio-oto-renal syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- branchiootorenal syndrome 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- branchiootic syndrome 1Inheritance: AD Classification: STRONG Submitted by: PanelApp Australia
- branchiootic syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 8-71215529-C-A is Benign according to our data. Variant chr8-71215529-C-A is described in ClinVar as Benign. ClinVar VariationId is 1253275.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.739 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| EYA1 | NM_000503.6 | c.1476-21G>T | intron_variant | Intron 15 of 17 | ENST00000340726.8 | NP_000494.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.320 AC: 48658AN: 151902Hom.: 8613 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
48658
AN:
151902
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.378 AC: 94834AN: 250698 AF XY: 0.374 show subpopulations
GnomAD2 exomes
AF:
AC:
94834
AN:
250698
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.323 AC: 471592AN: 1458716Hom.: 83186 Cov.: 33 AF XY: 0.325 AC XY: 236222AN XY: 725890 show subpopulations
GnomAD4 exome
AF:
AC:
471592
AN:
1458716
Hom.:
Cov.:
33
AF XY:
AC XY:
236222
AN XY:
725890
show subpopulations
African (AFR)
AF:
AC:
7939
AN:
33422
American (AMR)
AF:
AC:
22301
AN:
44684
Ashkenazi Jewish (ASJ)
AF:
AC:
9104
AN:
26104
East Asian (EAS)
AF:
AC:
30057
AN:
39676
South Asian (SAS)
AF:
AC:
37498
AN:
86198
European-Finnish (FIN)
AF:
AC:
18021
AN:
53396
Middle Eastern (MID)
AF:
AC:
1605
AN:
5762
European-Non Finnish (NFE)
AF:
AC:
324687
AN:
1109238
Other (OTH)
AF:
AC:
20380
AN:
60236
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.457
Heterozygous variant carriers
0
15057
30114
45170
60227
75284
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
11108
22216
33324
44432
55540
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.320 AC: 48712AN: 152020Hom.: 8629 Cov.: 33 AF XY: 0.329 AC XY: 24434AN XY: 74318 show subpopulations
GnomAD4 genome
AF:
AC:
48712
AN:
152020
Hom.:
Cov.:
33
AF XY:
AC XY:
24434
AN XY:
74318
show subpopulations
African (AFR)
AF:
AC:
10188
AN:
41456
American (AMR)
AF:
AC:
6318
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
AC:
1178
AN:
3470
East Asian (EAS)
AF:
AC:
3921
AN:
5168
South Asian (SAS)
AF:
AC:
2250
AN:
4800
European-Finnish (FIN)
AF:
AC:
3897
AN:
10568
Middle Eastern (MID)
AF:
AC:
93
AN:
294
European-Non Finnish (NFE)
AF:
AC:
19800
AN:
67980
Other (OTH)
AF:
AC:
702
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
1607
3214
4821
6428
8035
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
480
960
1440
1920
2400
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2142
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Branchiootic syndrome 1 Benign:1
Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Branchiootorenal syndrome 1 Benign:1
Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Otofaciocervical syndrome 1 Benign:1
Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.